Home > Who We Are > Our Strategy

We are advancing people’s health through the fusion of science, passion and ingenuity

Woman looking through microscope

Building the future of healthcare

We are a global healthcare company, born in Italy and shaped by a legacy of excellence and entrepreneurship, with people’s health at the heart of everything we do.

We combine deep scientific expertise with an ingenuity-driven, agile mindset to develop effective, innovative solutions and accelerate access for patients and consumers worldwide.

Operating across the full spectrum of healthcare – from consumer health to specialty care and rare diseases – we focus on digestive, vascular and immune systems to address some of the most critical health needs.

Bringing together more than 4,000 people, we work closely with healthcare professionals and partners so we can continue to innovate, broaden access and deliver meaningful impact for people’s health worldwide.

We see possibility where others see limits. We learn to dare. We are Alfasigma.

Delivering our strategy

The three pillars behind our vision

Ingenuity in action

Ingenuity is integral to everything we do. Doing things with ingenuity means we are driven by curiosity and creativity.

Science at the core

Science is our foundation – all our healthcare solutions are backed by world-class scientific processes and knowledge.

Passion for innovation

Passion leads us – we are constantly innovating because we care for patients, people and communities.

Long corridor in industrial setting, with a person in a white lab coat
Advancing Global Healthcare

We are continuously evolving, turning ideas into action

Over the past three years, we have come a long way together – growing our footprint, building something truly special and nearly doubling our revenue.

We have expanded into new territories, tackled rare and specialty segments, and brought in great people along the way.

But here is the thing – we are just getting started.

Combining the trust of established pharma with the speed of modern biotech, we are rewriting what is possible in drug development.

The best part? Our most exciting chapters are still being written.

Science & Innovation
OUR FOCUS

Digestive, vascular and immune systems

Driven by rigorous science, inspired by a legacy of ingenuity and focused on growth we develop innovative solutions to advance people’s health in areas of significant unmet needs across digestive, vascular and immune systems. We develop and deliver pharmaceutical solutions and healthcare products using a truly holistic, end-to-end approach. We address patient needs across the full spectrum of care – from prevention and everyday wellbeing to managing chronic, complex and rare diseases.

Explore our health areas

Our presence also extends to additional therapeutic areas, reflecting local healthcare priorities and patient needs

Explore our global presence

Our portfolio ranges from primary care, specialty care and rare-disease medications to consumer health products, including medical foods and nutraceuticals

Our products
Key stats

Alfasigma: driving global growth through innovation

78 years ago

Bologna headquarters, where it all began.

27 offices worldwide

From Italy to Europe, the US, Mexico, China and beyond.

100+ countries

Our products are available to people in Europe, North America, South America, Asia and Africa.

€1.8 billion

Our total turnover in 2025, driven by solid performance across key therapeutic areas and global markets.

More than 4,000 people

Dedicated to the development, production and distribution of pharmaceutical and consumer healthcare products.

2 R&D laboratory centres

and manufacturing plants in Italy, Spain and the US.